Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05682742 · ClinicalTrials.gov registry record · NA
Clinical Investigation of the da Vinci Surgical System
A NA study of Prostate Cancer and Gynecologic Cancer, sponsored by Intuitive Surgical.
- Active
- Registry status
- NA
- Development phase
- 53
- Enrollment target
- 4
- Study locations
NCT05682742: Active NA study of Prostate Cancer and Gynecologic Cancer, sponsored by Intuitive Surgical.
NCT05682742 is a NA study of Prostate Cancer and Gynecologic Cancer that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 53 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05682742, a NA study of Prostate Cancer and Gynecologic Cancer, is active but no longer recruiting, sponsored by Intuitive Surgical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
- 4
- Study locations
Study Summary
This prospective, multicenter, single-arm study is being conducted to confirm safety, effectiveness, and usability of da Vinci Surgical System in performing robotic-assisted surgical procedures.
Primary Outcome
Effectiveness defined as the ability to complete the planned da Vinci robotic-assisted procedures without conversion to open.
Conditions Studied
Interventions
- DEVICE Robotic-assisted Surgery
Study Locations (4)
Florida
- Orlando Health, Inc. - Orlando
Michigan
- Sparrow Health System - Lansing
New Jersey
- The Valley Hospital - Ridgewood
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What the registry record for NCT05682742 still lists
NCT05682742 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower).
The record links to 10 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Robotic-assisted Surgery is the first listed.
NCT05682742 reports a single indexed study location in Florida, Michigan, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05682742 about?
NCT05682742 is a clinical study titled "Clinical Investigation of the da Vinci Surgical System". This prospective, multicenter, single-arm study is being conducted to confirm safety, effectiveness, and usability of da Vinci Surgical System in performing robotic-assisted surgical procedures.
What is the current status of trial NCT05682742?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2022-12-12. Estimated completion is 2028-08-31.
What conditions does trial NCT05682742 study?
This clinical trial studies the following conditions: Prostate Cancer, Gynecologic Cancer, Pelvic Organ Prolapse, Obesity, Morbid, Ventral Hernia.
What interventions are being tested in trial NCT05682742?
The interventions under investigation include: Robotic-assisted Surgery (DEVICE).
Who is sponsoring clinical trial NCT05682742?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05682742 being conducted?
This trial has 4 study locations across Florida, Michigan, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05682742's enrollment target sits among peer trials
53 463rd of 735 higher than 272 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI